Vitamin C and the common cold
The common cold is caused by several groups of viruses including rhinoviruses, coronaviruses and respiratory syncytial virus. Colds are the leading cause of doctor's visits and the most common reason for absences from work and school. Research suggests that routine vitamin C supplementation may modestly reduce a cold's duration and severity for the general population. While therapeutic trials of the vitamin for treatment of the common cold show no significant changes in the risk of catching a cold in the general population, statistics indicate that its anti-oxidative properties halve the risk of catching a cold in people exposed to extreme physical stress. In brief, it is unclear to what extent an increased vitamin C intake before or during a cold may be helpful.
In the 1970s, Linus Pauling argued that vitamin C could significantly decrease the incidence of the common cold, which spurred a widespread belief that consuming more vitamin C will reduce the risk of catching a cold and reduce its severity. Spurred by Pauling's claims, NIH conducted one of the first double-blind, placebo-controlled studies of vitamin C. The results showed a moderate decrease in duration and severity of colds; however, a post-trial analysis by the authors suggested to them that the results may have been attributable to a failure of the double-blind protocol. A subsequent meta-analysis found only very minor reduction in duration, and the authors concluded that vitamin C had no value in treating the common cold.
In the past 40 years, numerous epidemiological and placebo-controlled trials have examined the effect of vitamin C supplementation on the prevention and treatment of colds. More than 30 clinical trials with over 10,000 participants have examined the effects of taking daily vitamin C in doses up to 2 g/day. The majority of studies of non-athletic people, when looked at collectively, led researchers to conclude that vitamin C does not prevent or treat the common cold, but highly physically active people training in stressful conditions (e.g. soldiers training in the Arctic) may benefit from supplementation. A 2009 literature review concluded that vitamin C consumption may decrease the duration of cold symptoms in some populations, but does not prevent a cold or affect symptom severity.
A 2013 Cochrane systematic review of placebo-controlled trials using vitamin C doses of at least 200 mg/day found that routine vitamin C supplementation did not prevent colds in the general population, but halved the common cold risk in people exposed to short periods of extreme physical stress, shortened colds by 8 percent in adults and up to 18 percent in children, and reduced severity of symptoms. Only seven clinical trials tested vitamin C as a treatment after the onset of cold symptoms, and three of those trials showed a benefit, but considering the benefits of routine vitamin C supplementation, the review concludes, "it may be worthwhile for common cold patients to test on an individual basis whether therapeutic vitamin C is beneficial for them."
A systematic review of vitamin C for cold-induced asthma found three relevant studies, all of which found benefits from the administration of vitamin C, either against asthma attacks or against bronchial hypersensitivity that is a characteristic of asthma.
Sources of vitamin C
Generally, nutrients have more bioavailability in naturally occurring food sources. However, ascorbic acid’s bioavailability is equal in both food and supplemental sources. Therefore, while it is better to consume natural foods such as red peppers, oranges, strawberries and grapefruit, because they offer other nutrients that are likely to have a higher bioavailability, it is acceptable to consume vitamin C from a supplement and still maintain adequate intake levels.
- Douglas RM, Hemilä H (June 2005). "Vitamin C for Preventing and Treating the Common Cold". PLoS Medicine. 2 (6): e168; quiz e217. doi:10.1371/journal.pmed.0020168. PMC . PMID 15971944.
- Hemilä H, Chalker E (January 2013). "Vitamin C for preventing and treating the common cold". Cochrane Database of Systematic Reviews. 1: CD000980. doi:10.1002/14651858.CD000980.pub4. PMID 23440782.
- "The Difference Between Dr. Linus Pauling's Recommendations and the Linus Pauling Institute's Recommendation for Vitamin C Intake". January 27, 2004. Retrieved November 1, 2010.
- Karlowski, TR; Chalmers TC; Frenkel LD; Kapikian AZ; Lewis TL; Lynch JM. (March 1975). "Ascorbic acid for the common cold. A prophylactic and therapeutic trial.". JAMA. 231 (10): 1038–42. doi:10.1001/jama.1975.03240220018013. PMID 163386. Retrieved 4 February 2013.
- Chalmers, TC (April 1975). "Effects of ascorbic acid on the common cold. An evaluation of the evidence.". Am J Med. 58 (4): 532–6. doi:10.1016/0002-9343(75)90127-8. PMID 1092164.
- Heimer, K. A.; Hart, A. M.; Martin, L. G.; Rubio-Wallace, S. (2009). "Examining the evidence for the use of vitamin C in the prophylaxis and treatment of the common cold". Journal of the American Academy of Nurse Practitioners. 21 (5): 295–300. doi:10.1111/j.1745-7599.2009.00409.x. PMID 19432914.
- Hemilä, Harri (26 November 2013). "Vitamin C and common cold-induced asthma: a systematic review and statistical analysis". Allergy, Asthma & Clinical Immunology. 9: 46. doi:10.1186/1710-1492-9-46. PMID 24279478. Retrieved 2015-11-01.
- GF Ball. Vitamins: their role in the human body. Blackwell Science. pp. 395–415.
- D Garriguet (March 2006). "The effect of supplement on vitamin C intake". Health Reports. 21 (1): 57–62. PMID 20426227.